Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
D000241:Adenosine / Q000494:pharmacology*; D000961:Antilymphocyte Serum; D001081:Apyrase / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology*; D005480:Flurbiprofen / Q000494:pharmacology*; D006801:Humans; D010744:Phosphoric Monoester Hydrolases / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011422:Propionates / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology*; D013442:Sulfinpyrazone / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum; D011422:Propionates; D011458:Prostaglandins E; D005480:Flurbiprofen; D004176:Dipyridamole; D010744:Phosphoric Monoester Hydrolases; D001081:Apyrase; D000241:Adenosine; D001241:Aspirin; D013442:Sulfinpyrazone